On Sept 11, 2026, in San Diego, Dare Bioscience, Inc. (NASDAQ: DARE) released an on-demand webcast of its presentation at the H.C. Wainwright 28th Annual Global Investment Conference.
The company, identified as a purpose‑driven health biotechnology firm, used the forum to address investors and industry analysts, underscoring its mission‑focused approach to therapeutic development.
ALSO READ | Gov. Newsom’s Failed Fight to Block Billionaire Tax Tests Presidential Prospects
The Globe Newswire release provides a link to the video, noting that the on-demand access is part of the conference’s effort to disseminate corporate updates to the broader investment community.
